2022
High pre-diagnosis inflammation-related risk score associated with decreased ovarian cancer survival
Brieger KK, Phung MT, Mukherjee B, Bakulski KM, Anton-Culver H, Bandera EV, Bowtell DDL, Cramer DW, DeFazio A, Doherty JA, Fereday S, Fortner RT, Gentry-Maharaj A, Goode EL, Goodman MT, Harris HR, Matsuo K, Menon U, Modugno F, Moysich KB, Qin B, Ramus SJ, Risch HA, Rossing MA, Schildkraut JM, Trabert B, Vierkant RA, Winham SJ, Wentzensen N, Wu AH, Ziogas A, Khoja L, Cho KR, McLean K, Richardson J, Grout B, Chase A, Deurloo CM, Odunsi K, Nelson BH, Brenton JD, Terry KL, Pharaoh P, Berchuck A, Hanley GE, Webb PM, Pike MC, Pearce CL. High pre-diagnosis inflammation-related risk score associated with decreased ovarian cancer survival. Cancer Epidemiology Biomarkers & Prevention 2022, 31: cebp.epi-21-0977-a.2021. PMID: 34789471, PMCID: PMC9281656, DOI: 10.1158/1055-9965.epi-21-0977.Peer-Reviewed Original ResearchConceptsOvarian cancer survivalCox proportional hazards modelProportional hazards modelCancer survivalOvarian cancerRisk scoreHazards modelNonsteroidal anti-inflammatory drug useAnti-inflammatory drug useMenopausal hormone therapy useEnvironmental tobacco smoke exposureInvasive epithelial ovarian cancerHormone therapy usePelvic inflammatory diseaseInflammation-related factorsPolycystic ovarian syndromeTobacco smoke exposureBody mass indexRisk of deathEpithelial ovarian cancerOvarian Cancer Association ConsortiumOvarian cancer diagnosisHigh death rateAspirin useOvarian syndrome
2010
Risk of colorectal cancer in self‐reported inflammatory bowel disease and modification of risk by statin and NSAID use
Samadder N, Mukherjee B, Huang S, Ahn J, Rennert H, Greenson J, Rennert G, Gruber S. Risk of colorectal cancer in self‐reported inflammatory bowel disease and modification of risk by statin and NSAID use. Cancer 2010, 117: 1640-1648. PMID: 21472711, PMCID: PMC3117060, DOI: 10.1002/cncr.25731.Peer-Reviewed Original ResearchConceptsRisk of colorectal cancerAssociated with reduced risk of colorectal cancerHistory of inflammatory bowel diseaseRisk of inflammatory bowel diseaseAssociated with reduced riskLong-term statin useColorectal cancerMolecular Epidemiology of Colorectal Cancer studyPersonal history of inflammatory bowel diseaseIncreased risk of CRCReduced risk of colorectal cancerRelative riskIBD-associated colorectal cancerIncident colorectal cancerNonsteroidal anti-inflammatory drugsUnconditional logistic regressionNonsteroidal anti-inflammatory drug useStatin useModification of riskReduced riskInflammatory bowel diseaseColorectal cancer studyIn-person interviewsNon-IBD colorectal cancersCase-control study